Rajan Sharma
Stock Analyst at Goldman Sachs
(0.07)
# 4,482
Out of 5,182 analysts
5
Total ratings
25%
Success rate
-41.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $21.04 | -65.54% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $203.49 | -52.33% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $56.69 | -17.09% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $30.83 | +156.24% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $21.04
Upside: -65.54%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $203.49
Upside: -52.33%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $56.69
Upside: -17.09%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $30.83
Upside: +156.24%